Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
Marcia L. Moss(BioZyme (United States)), Raphael Nudelman(Applied Materials (Israel)), Liora Sklair‐Tavron(Teva Pharmaceuticals (Israel))
Cited by 197
Related Papers
OxyR
|Cell|2002|474
S-nitrosylation: spectrum and specificity
|Nature Cell Biology|2001|243
An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT<sub>1A</sub> Agonist (PRX-00023) for the Treatment of Anxiety and Depression
|Journal of Medicinal Chemistry|2006|141
A nitric oxide processing defect of red blood cells created by hypoxia: Deficiency of S-nitrosohemoglobin in pulmonary hypertension
|Proceedings of the National Academy of Sciences|2005|132
Modular Fluorescent-Labeled Siderophore Analogues
|Journal of Medicinal Chemistry|1998|103